Verastem, Inc. (VSTM)
8.695
+0.28
(+3.39%)
USD |
NASDAQ |
Nov 09, 16:00
8.695
0.00 (0.00%)
After-Hours: 17:49
Verastem Gross Profit (Annual) : 25.62M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 25.62M |
| December 31, 2024 | 9.974M |
| December 31, 2023 | -0.062M |
| December 31, 2022 | -0.118M |
| December 31, 2021 | 0.40M |
| December 31, 2020 | 15.43M |
| December 31, 2019 | 14.22M |
| December 31, 2018 | 25.13M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.556M |
| December 31, 2016 | -0.67M |
| December 31, 2015 | -0.754M |
| December 31, 2014 | -0.427M |
| December 31, 2013 | -0.236M |
| December 31, 2012 | -0.207M |
| December 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Cytokinetics, Inc. | 77.91M |
| Inovio Pharmaceuticals, Inc. | -2.924M |
| Rigel Pharmaceuticals, Inc. | 274.66M |
| United Therapeutics Corp. | 2.798B |
| SELLAS Life Sciences Group, Inc. | 0.00 |